The receptor tyrosine kinase EphB4 and its preferred membrane-bound ligand ephrinB2 play a crucial role in both physiological angiogenesis and lymphangiogenesis during embryonic development as well as in pathophysiological processes such as tumor angiogenesis [1,2,3,4,5]. Here, EPHB4 is linked to neoplasm.